Share Prophets

Wednesday 14 November 2018 | ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code

Akers Biosciences – a class action lawsuit received & seemingly others to follow, keep running for the hills from this stock!

2018-06-21 04:28:22

Writing on Akers Biosciences (AKR & NASDAQ - AKER) last month - “decided to withdraw” an initial FDA application… & worse, I concluded to run for the hills from this stock. Now, the shares are slumping again – this time on a “Notification of Class Action” announcement. Uh oh…

Akers Biosciences – “decided to withdraw” an initial FDA application… & worse

2018-05-30 09:27:29

A slump in shares in Akers Biosciences (AKR & NASDAQ - AKER) was noted in Bearcast yesterday, what’s the detail?...

Akers Biosciences Buy at 3.55p - U Shaped Recovery Targets 7p

2013-11-18 11:53:22

 

The ideal scenario as far as charting a stock or market is concerned is that you do not necessarily have to do the dirty work in terms of trying to work out what will happen next – the price action does it for you.

Buy Akers Biosciences at 2.375p – short term target 4.5p

2013-10-08 10:11:44

Interesting "players" in the small cap world are buying into AIM listed Akers Biosciences (AKR) and we suggest following suit at 2.375p with an initial target of 4.5p. Here’s why.

Search ShareProphets |

Recent Comments |




About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen